Giant cell arteritis (GCA): treatment
Evidence-based neurology checklist on giant cell arteritis (gca): treatment: Methylprednisolone The dose is 500mg-1g daily for 3 days It is indicated for visual loss or amaurosis fugax Prednisolone Adjunctive immunosuppression Other treatments Investigational treatments Synonym
Methylprednisolone
- The dose is 500mg-1g daily for 3 days
- It is indicated for visual loss or amaurosis fugax
Prednisolone
Adjunctive immunosuppression
Other treatments
Investigational treatments
Synonym
References
- Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rhaumatology (Oxford) 2010; 49:1594-1597.
- Calvo-Romero JM. Giant cell arteritis. Postgrad Med J 2003; 79:511-515.
- Lyons HS, Quick V, Sinclair AJ, Nagaraju S, Mollan SP. A new era for giant cell arteritis. Eye (Lond) 2019; doi: 10.1038/s41433-019-0608-7 (Epub ahead of print).
- Jivraj I, Tamhankar M. The treatment of giant cell arteritis. Curr Treat Options Neurol 2017; 19:2.
- Watelet B, Samson M, de Boysson H, Bienvenu B. Treatment of giant-cell arteritis, a literature review. Mod Rheumatol 2017; 27:747-754.
- And 6 more. Subscribe to see the full list
